168Indexed trials
Market Rank #16 · Evidence Tier A
Brazil
Neuroscience Intelligence
Brazil neuroscience intelligence: 168 indexed trials, 119 institutions, research score 40.92.
38Recruiting
119Research institutions
40.9Research score
Evidence profile
68Sponsors
23Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 40.9 · Data confidence 100.00 · Evidence 40.9
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
parkinsons47trials
alzheimers22trials
pain_neuropathy14trials
adhd12trials
epilepsy12trials
depression8trials
multiple_sclerosis8trials
stroke7trials
autism6trials
schizophrenia6trials
Leading indexed sponsors
Merck Sharp & Dohme LLC18trials
Hoffmann-La Roche12trials
University of Sao Paulo11trials
Hospital de Clinicas de Porto Alegre10trials
University of Sao Paulo General Hospital10trials
Federal University of Paraíba7trials
Federal University of Rio Grande do Sul7trials
Universidade Federal de Pernambuco7trials
Federal University of Minas Gerais4trials
GlaxoSmithKline4trials